These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10360079)

  • 21. Esmolol and the adrenergic response to perioperative stimuli.
    Murthy VS; Hwang TF; Sandage BW; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A27-A35. PubMed ID: 2870083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion in combination with Esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients.
    Borowski A; Raji MR; Eichstaedt HC; Schickendantz S; Korb H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):243-9. PubMed ID: 9761432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the beta-adrenergic blocking drug Kö 1366 on haemodynamics in healthy volunteers and patients with ischaemic heart disease.
    Miyahara M; Fujise Y; Osanai S; Takada T
    Jpn Heart J; 1974 Sep; 15(5):455-68. PubMed ID: 4155008
    [No Abstract]   [Full Text] [Related]  

  • 24. Does esmolol block the cardiovascular response to intubation?
    James RH
    Anaesthesia; 1997 Nov; 52(11):1119. PubMed ID: 9404186
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasodilatory action of carvedilol.
    Sponer G; Strein K; Bartsch W; Müller-Beckmann B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia.
    Oxorn D; Knox JW; Hill J
    Can J Anaesth; 1990 Mar; 37(2):206-9. PubMed ID: 1968784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bolus dose of esmolol attenuates tachycardia and hypertension after tracheal intubation.
    Sheppard S; Eagle CJ; Strunin L
    Can J Anaesth; 1990 Mar; 37(2):202-5. PubMed ID: 1968783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of side effects of vasodilators with beta-blockers. synergistic effect of beta-blockers in combination with vasodilators in reducing blood pressure.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):94-6. PubMed ID: 14628
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenergic blockade in hypertension.
    Metha J
    JAMA; 1978 Oct; 240(16):1759-60. PubMed ID: 29138
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
    Forrest EH; Bouchier IA; Hayes PC
    J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G; Ruffolo RR
    Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of beta-adrenoceptor blocking agents on haemodynamic parameters.
    Hansson L
    Acta Med Scand Suppl; 1977; 606():49-54. PubMed ID: 19930
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels].
    Fernández-Andrade C; Herrera Carranza M; Villalobos Galán E; Mateos Aguilar J; Quereda C; Navarro R; Martinez Martin A; Mendoza Llera M
    Rev Clin Esp; 1978 Mar; 148(5):491-6. PubMed ID: 27844
    [No Abstract]   [Full Text] [Related]  

  • 38. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.